JOHN K. BAKEWELL - 17 May 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa O. Taylor as Attorney-in-fact John K. Bakewell
Issuer symbol
TMCI
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 20:33:14 UTC
Previous filing
11 Feb 2022
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +2,295 $0.000000 2,295 17 May 2022 Direct F1
holding TMCI Common Stock 250,000 17 May 2022 Deborah M. Bakewell, as Trustee of family trust #1
holding TMCI Common Stock 92,300 17 May 2022 John K. Bakewell, as Trustee of family trust #2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +16,625 $0.000000 16,625 17 May 2022 Common Stock 16,625 $15.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.
F2 The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date.